Allspring Global Investments Holdings, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$1.8 - $2.56 $322 - $458
-179 Reduced 2.15%
8,160 $0
Q3 2022

Oct 26, 2022
SELL
$1.94 - $3.43 $16,848 - $29,789
-8,685 Reduced 51.02%
8,339 $20,000
Q2 2022

Jul 25, 2022
SELL
$1.31 - $2.69 $244,616 - $502,303
-186,730 Reduced 91.64%
17,024 $31,000
Q1 2022

May 02, 2022
SELL
$1.95 - $3.89 $721,002 - $1.44 Million
-369,745 Reduced 64.47%
203,754 $425,000
Q4 2021

Jan 28, 2022
BUY
$3.81 - $6.16 $2.19 Million - $3.53 Million
573,499 New
573,499 $2.26 Million

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email